Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MSLP > SEC Filings for MSLP > Form 8-K/A on 12-Nov-2013All Recent SEC Filings

Show all filings for MUSCLEPHARM CORP

Form 8-K/A for MUSCLEPHARM CORP


12-Nov-2013

Other Events


ITEM 8.01 OTHER INFORMATION

MusclePharm Corporation (the "Company") has sent to MusclePharm Sportswear LLC ("MPS") a Notice of Intent to Terminate pursuant to the MusclePharm Sportswear License Agreement ("Agreement") dated June 2011, due to a material breach by MPS, thereby initiating a 30-day cure period (the "Cure Period") during which time MPS may cure the material breach of the Agreement. If MPS fails, refuses or is unable for any reason to cure such breach during the Cure Period, the Company may terminate the Agreement upon three (3) days written notice to MPS. Accordingly, if MPS fails to cure such breach during the Cure period, and the Company terminates the Agreement, the Company shall no longer have any affiliation with MPS and its principle owner, Drew Ciccarelli. The Company will demand that, within thirty (30) days from the date of termination of the Agreement, MPS dissolve its company and stop using the name "MusclePharm" and/or "MusclePharm Sportswear LLC" in any manner or any fashion.

  Add MSLP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MSLP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.